Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.

Rudrabhatla P, Jaffe H, Pant HC.

FASEB J. 2011 Nov;25(11):3896-905. doi: 10.1096/fj.11-181297. Epub 2011 Aug 9.

2.

Vimentin in cancer and its potential as a molecular target for cancer therapy.

Satelli A, Li S.

Cell Mol Life Sci. 2011 Sep;68(18):3033-46. doi: 10.1007/s00018-011-0735-1. Epub 2011 Jun 3. Review.

3.

Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation.

Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, Liu Y, Tighiouart M, Vertino PM, Harvey RD, Garcia A, Marcus AI.

Int J Cancer. 2011 Dec 1;129(11):2744-55. doi: 10.1002/ijc.25938. Epub 2011 May 2.

4.

Vimentin organization modulates the formation of lamellipodia.

Helfand BT, Mendez MG, Murthy SN, Shumaker DK, Grin B, Mahammad S, Aebi U, Wedig T, Wu YI, Hahn KM, Inagaki M, Herrmann H, Goldman RD.

Mol Biol Cell. 2011 Apr 15;22(8):1274-89. doi: 10.1091/mbc.E10-08-0699. Epub 2011 Feb 23.

5.

Plectin interacts with the rod domain of type III intermediate filament proteins desmin and vimentin.

Favre B, Schneider Y, Lingasamy P, Bouameur JE, Begré N, Gontier Y, Steiner-Champliaud MF, Frias MA, Borradori L, Fontao L.

Eur J Cell Biol. 2011 May;90(5):390-400. doi: 10.1016/j.ejcb.2010.11.013. Epub 2011 Feb 5.

PMID:
21296452
6.

Vimentin is a novel AKT1 target mediating motility and invasion.

Zhu QS, Rosenblatt K, Huang KL, Lahat G, Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, Luo X, Lazar A, Dicker A, Mills GB, Hung MC, Lev D.

Oncogene. 2011 Jan 27;30(4):457-70. doi: 10.1038/onc.2010.421. Epub 2010 Sep 20.

7.

Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ.

Rudrabhatla P, Grant P, Jaffe H, Strong MJ, Pant HC.

FASEB J. 2010 Nov;24(11):4396-407. doi: 10.1096/fj.10-157859. Epub 2010 Jul 12.

8.

Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies.

Lahat G, Zhu QS, Huang KL, Wang S, Bolshakov S, Liu J, Torres K, Langley RR, Lazar AJ, Hung MC, Lev D.

PLoS One. 2010 Apr 16;5(4):e10105. doi: 10.1371/journal.pone.0010105.

9.

Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition.

Mendez MG, Kojima S, Goldman RD.

FASEB J. 2010 Jun;24(6):1838-51. doi: 10.1096/fj.09-151639. Epub 2010 Jan 22.

10.

Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis.

Bargagna-Mohan P, Paranthan RR, Hamza A, Dimova N, Trucchi B, Srinivasan C, Elliott GI, Zhan CG, Lau DL, Zhu H, Kasahara K, Inagaki M, Cambi F, Mohan R.

J Biol Chem. 2010 Mar 5;285(10):7657-69. doi: 10.1074/jbc.M109.093765. Epub 2010 Jan 4.

11.

Withaferin A targets heat shock protein 90 in pancreatic cancer cells.

Yu Y, Hamza A, Zhang T, Gu M, Zou P, Newman B, Li Y, Gunatilaka AA, Zhan CG, Sun D.

Biochem Pharmacol. 2010 Feb 15;79(4):542-51. doi: 10.1016/j.bcp.2009.09.017.

12.

Neurofilaments bind tubulin and modulate its polymerization.

Bocquet A, Berges R, Frank R, Robert P, Peterson AC, Eyer J.

J Neurosci. 2009 Sep 2;29(35):11043-54. doi: 10.1523/JNEUROSCI.1924-09.2009.

13.

The dynamic properties of intermediate filaments during organelle transport.

Chang L, Barlan K, Chou YH, Grin B, Lakonishok M, Serpinskaya AS, Shumaker DK, Herrmann H, Gelfand VI, Goldman RD.

J Cell Sci. 2009 Aug 15;122(Pt 16):2914-23. doi: 10.1242/jcs.046789. Epub 2009 Jul 28.

14.

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.

Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD, El-Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Gronemeyer H, Hajnóczky G, Hardwick JM, Hengartner MO, Ichijo H, Jäättelä M, Kepp O, Kimchi A, Klionsky DJ, Knight RA, Kornbluth S, Kumar S, Levine B, Lipton SA, Lugli E, Madeo F, Malomi W, Marine JC, Martin SJ, Medema JP, Mehlen P, Melino G, Moll UM, Morselli E, Nagata S, Nicholson DW, Nicotera P, Nuñez G, Oren M, Penninger J, Pervaiz S, Peter ME, Piacentini M, Prehn JH, Puthalakath H, Rabinovich GA, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Scorrano L, Simon HU, Steller H, Tschopp J, Tsujimoto Y, Vandenabeele P, Vitale I, Vousden KH, Youle RJ, Yuan J, Zhivotovsky B, Kroemer G.

Cell Death Differ. 2009 Aug;16(8):1093-107. doi: 10.1038/cdd.2009.44. Epub 2009 Apr 17. Review.

15.

Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation.

Oh JH, Lee TJ, Kim SH, Choi YH, Lee SH, Lee JM, Kim YH, Park JW, Kwon TK.

Apoptosis. 2008 Dec;13(12):1494-504. doi: 10.1007/s10495-008-0273-y.

PMID:
19002588
16.

Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade.

Mandal C, Dutta A, Mallick A, Chandra S, Misra L, Sangwan RS, Mandal C.

Apoptosis. 2008 Dec;13(12):1450-64. doi: 10.1007/s10495-008-0271-0.

PMID:
18987975
17.

Analysis of cellular senescence in culture in vivo: the senescence-associated beta-galactosidase assay.

Bandyopadhyay D, Gatza C, Donehower LA, Medrano EE.

Curr Protoc Cell Biol. 2005 Jul;Chapter 18:Unit 18.9. doi: 10.1002/0471143030.cb1809s27.

PMID:
18228464
18.

The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases.

Szeverenyi I, Cassidy AJ, Chung CW, Lee BT, Common JE, Ogg SC, Chen H, Sim SY, Goh WL, Ng KW, Simpson JA, Chee LL, Eng GH, Li B, Lunny DP, Chuon D, Venkatesh A, Khoo KH, McLean WH, Lim YP, Lane EB.

Hum Mutat. 2008 Mar;29(3):351-60.

PMID:
18033728
19.

The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin.

Bargagna-Mohan P, Hamza A, Kim YE, Khuan Abby Ho Y, Mor-Vaknin N, Wendschlag N, Liu J, Evans RM, Markovitz DM, Zhan CG, Kim KB, Mohan R.

Chem Biol. 2007 Jun;14(6):623-34.

20.

Plakins in development and disease.

Sonnenberg A, Liem RK.

Exp Cell Res. 2007 Jun 10;313(10):2189-203. Epub 2007 Apr 19. Review.

PMID:
17499243

Supplemental Content

Support Center